Skip to main content
SpringerLink
Log in

Effects of Psychotropic Drugs on Seizure Threshold

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Psychotropic drugs, especially antidepressants and antipsychotics, may give rise to some concern in clinical practice because of their known ability to reduce seizure threshold and to provoke epileptic seizures. Although the phenomenon has been described with almost all the available compounds, neither its real magnitude nor the seizurogenic potential of individual drugs have been clearly established so far. In large investigations, seizure incidence rates have been reported to range from ∼0.1 to ∼1.5% in patients treated with therapeutic doses of most commonly used antidepressants and antipsychotics (incidence of the first unprovoked seizure in the general population is 0.07 to 0.09%). In patients who have taken an overdose, the seizure risk rises markedly, achieving values of ∼4 to ∼30%. This large variability, probably due to methodological differences among studies, makes data confusing and difficult to interpret. Agreement, however, converges on the following: seizures triggered by psychotropic drugs are a dose-dependent adverse effect; maprotiline and clomipramine among antidepressants and chlorpromazine and clozapine among antipsychotics that have a relatively high seizurogenic potential; phenelzine, tranylcypromine, fluoxetine, paroxetine, sertraline, venlafaxine and trazodone among antidepressants and fluphenazine, haloperidol, pimozide and risperidone among antipsychotics that exhibit a relatively low risk. Apart from drug-related factors, seizure precipitation during psychotropic drug medication is greatly influenced by the individual’s inherited seizure threshold and, particularly, by the presence of seizurogenic conditions (such as history of epilepsy, brain damage, etc.). Pending identification of compounds with less or no effect on seizure threshold and formulation of definite therapeutic guidelines especially for patients at risk for seizures, the problem may be minimised through careful evaluation of the possible presence of seizurogenic conditions and simplification of the therapeutic scheme (low starting doses/slow dose escalation, maintenance of the minimal effective dose, avoidance of complex drug combinations, etc.). Although there is sufficient evidence that psychotropic drugs may lower seizure threshold, published literature data have also suggested that an appropriate psychotropic therapy may not only improve the mental state in patients with epilepsy, but also exert antiepileptic effects through a specific action. Further scientific research is warranted to clarify all aspects characterising the complex link between seizure threshold and psychotropic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Fig. 2
Table II
Fig. 3
Fig. 4
Table III
Fig. 5
Fig. 6
Table IV

Similar content being viewed by others

References

  1. Reynolds EH, Trimble MR, editors. Epilepsy and psychiatry. Edinburgh: Churchill Livingstone, 1981

    Google Scholar 

  2. Edwards JG, Long KS, Sedgwick EM, et al. Antidepressants and convulsive seizures: clinical, electroencephalographic and pharmacological aspects. Clin Neuropharm 1986; 9: 329–60

    Article  CAS  Google Scholar 

  3. Robertson MM. The organic contribution to depressive illness in patients with epilepsy. J Epilepsy 1989; 2: 189–223

    Article  Google Scholar 

  4. Matthews WS, Barabas G. Suicide and epilepsy: a review of the literature. Psychosomatics 1981; 22: 515–24

    PubMed  CAS  Google Scholar 

  5. Anton-Stephens D. Preliminary observations on the psychiatric use of chlorpromazine. J Ment Sci 1953; 100: 543–7

    Google Scholar 

  6. Leyberg JT, Denmark JC. The treatment of depressive states with imipramine hydrochloride (Tofranil). J Ment Sci 1959; 105: 1123–6

    PubMed  CAS  Google Scholar 

  7. Blair D. Treatment of severe depression by imipramine: an investigation of 100 cases. J Ment Sci 1960; 106: 891–905

    Google Scholar 

  8. Sharp WL. Convulsions associated with anti-depressant drugs. Am J Psychiatry 1960; 117: 458–9

    Google Scholar 

  9. Kiloh LG, Davison K, Ossleton JW. An electroencephalographic study on the analeptic effects of imipramine. Electroencephalogr Clin Neurophysiol 1961; 12: 165–72

    Google Scholar 

  10. Davison K. EEG activation after intravenous amitriptyline. Electroencephalogr Clin Neurophysiol 1965; 19: 298–300

    Article  PubMed  CAS  Google Scholar 

  11. Redding FK. EEG activation with amitriptyline. Electroencephalogr Clin Neurophysiol 1969; 26: 630–6

    Article  Google Scholar 

  12. Legg NJ, Swash M. Clinical note: seizures and EEG activation after trimipramine. Epilepsia 1974; 15: 131–5

    Article  PubMed  CAS  Google Scholar 

  13. Rumpl E, Hinterhuber H. Unusual spike-wave stupor in a patient with manic-depressive psychosis treated with amitriptyline. J Neurol 1981; 226: 131–5

    Article  PubMed  CAS  Google Scholar 

  14. Meldrum B, Anlezark G, Trimble M. Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in papio papio. Eur J Pharmacol 1975; 32: 203–13

    Article  PubMed  CAS  Google Scholar 

  15. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975; 16: 1–66

    Article  PubMed  CAS  Google Scholar 

  16. Peck AW, Stern WC, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion. J Clin Psychiat 1983; 44: 197–201

    CAS  Google Scholar 

  17. Jick H, Dinan BJ, Hunter JR, et al. Tricyclic antidepressant and convulsions. J Clin Pharmacol 1983; 3: 182–5

    CAS  Google Scholar 

  18. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993; 54: 289–99

    PubMed  CAS  Google Scholar 

  19. Dessain EC, Schatzberg AF, Woods BT, et al. Maprotiline treatment in depression: a perspective on seizures. Arch Gen Psychiatry 1986; 43: 86–90

    Article  PubMed  CAS  Google Scholar 

  20. Physician’s Desk Reference. Prozac. Montvale (NJ): Medical Economics, 1992: 921

  21. Edwards JG, Inman WHW, Wilton L, et al. Prescription-event monitoring of 10401 patients treated with fluvoxamine. Br J Psychiatry 1994; 164: 387–95

    Article  PubMed  CAS  Google Scholar 

  22. Logothetis J. Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology 1967; 17: 869–77

    Article  PubMed  CAS  Google Scholar 

  23. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology 1991; 41(3): 369–71

    Article  PubMed  CAS  Google Scholar 

  24. Pacia SV, Devinsky O. Clozapine-related seizures: experience with 5,629 patients. Neurology 1994; 44: 2247–9

    Article  PubMed  CAS  Google Scholar 

  25. Stimmel GL, Dopheide JA. Psychotropic drug-induced reductions in seizure threshold: incidence and consequences. CNS Drugs 1996; 5: 37–50

    Article  CAS  Google Scholar 

  26. Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999; 53Suppl. 2: 68–75

    Google Scholar 

  27. Quitkin F, Rifkin A, Klein DF. Very high dosage versus standard dosage fluphenazine in schizophrenia. Arch Gen Psychiatry 1975; 32: 1276–81

    Article  PubMed  CAS  Google Scholar 

  28. Acri AA, Henretig FM. Effects of risperidone in overdose. Am J Emerg Med 1998; 16: 498–501

    Article  PubMed  CAS  Google Scholar 

  29. Leber P. Adverse drug reactions -‘time-less’ risks (a hazard of risk assessment: the example of seizure and antidepressants). Psychopharmacol Bull 1985; 21: 334–8

    PubMed  CAS  Google Scholar 

  30. Marks RC, Luchins DJ. Antipsychotic medications and seizures. Psychiatr Med 1991; 9(1): 37–52

    PubMed  CAS  Google Scholar 

  31. Lewis JA. Post-marketing surveillance: how many patients? Trends Pharmacol Sci 1981; 2: 93–4

    Article  Google Scholar 

  32. Lavoie FW, Gansert GG, Weiss RE. Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose. Ann Emerg Med 1990; 19: 696–700

    Article  PubMed  CAS  Google Scholar 

  33. Delay J, Deniker P. Efficacy of Tofranil in the treatment of various types of depression: a comparison with other antidepressant drugs. Can Psychiatr Ass J 1959; 4: 100–12

    Google Scholar 

  34. Freyhan FA. Clinical effectiveness of Tofranil in the treatment of depressive psychoses. Can Psychiatr Ass J 1959; 4: 86–9

    Google Scholar 

  35. Burley DM. A brief note on the problem of epilepsy in antidepressant treatment. In: Jukes A, editor. Depression: the biochemical and physiologic role of Ludiomil. Horsham (UK): Ciba, 1977: 201–3

    Google Scholar 

  36. Jabbari B, Bryan G, Mars LE, et al. Incidence of seizures with tricyclic and tetracyclic antidepressants. Arch Neurol 1985; 42: 480–1

    Article  PubMed  CAS  Google Scholar 

  37. Lowry MR, Dunner FJ. Seizures during tricyclic therapy. Am J Psychat 1980; 137: 1461–2

    CAS  Google Scholar 

  38. Jus A, Villeneuve A, Gautier J, et al. Influence of lithium carbonate on patients with temporal epilepsy. Can Psychiatr Assoc J 1973; 18: 77–8

    PubMed  CAS  Google Scholar 

  39. Betts TA, Kalra PL, Cooper R, et al. Epileptic fits as a probable side-effect of amitriptyline: report of seven cases. Lancet 1968; I: 390–2

    Article  Google Scholar 

  40. Dallos V, Heathfield K. Iatrogenic epilepsy due to antidepressant drugs. BMJ 1969; 4: 80–2

    Article  PubMed  CAS  Google Scholar 

  41. Edwards JG, Glen-Bott M. Mianserin and convulsive seizures. Br J Clin Pharmacol 1983; 15: 299–311

    Article  Google Scholar 

  42. Alldredge BK. Drug induced seizures: controversies in their identification and management. Pharmacotherapy 1997; 17: 857–60

    PubMed  CAS  Google Scholar 

  43. Wroblewski BA, McColgan K, Smith K, et al. The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 1990; 10: 124–8

    Article  PubMed  CAS  Google Scholar 

  44. Michals ML, Crismon ML, Roberts S, et al. Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol 1993; 13: 198–203

    Article  PubMed  CAS  Google Scholar 

  45. Franson KL, Hay DP, Neppe V, et al. Drug-induced seizures in the elderly: causative agents and optimal management. Drugs Aging 1995; 7(1): 38–48

    Article  PubMed  CAS  Google Scholar 

  46. Spigset O, Hedenmalm K, Dahl ML, et al. Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors. Acta Psychiatr Scand 1997; 96: 379–84

    Article  PubMed  CAS  Google Scholar 

  47. Itil TM, Soldatos C. Epileptogenic side effects of psychotropic drugs. JAMA 1980; 244: 1460–3

    Article  PubMed  CAS  Google Scholar 

  48. Physicians’ desk reference. Montvale (NJ): Medical Economics, 1999

  49. Dailey JW, Naritoku DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 1996; 52: 1323–9

    Article  PubMed  CAS  Google Scholar 

  50. Duncan D, Taylor D. Which is the safest antidepressant to use in epilepsy? Psychiatr Bull 1995; 19: 355–7

    Article  Google Scholar 

  51. Trimble MR. Non-monoamine oxidase inhibitor antidepressants and epilepsy: a review. Epilepsia 1978; 19: 241–50

    Article  PubMed  CAS  Google Scholar 

  52. Starkey IR, Lawson AA. Poisoning with tricyclic and related antidepressant: a ten year review. Q J Med 1980; 193: 33–49

    Google Scholar 

  53. Biggs JT, Spiker DG, Petit JM, et al. Tricyclic antidepressant overdose: incidence of symptoms. JAMA 1977; 238: 135–8

    Article  PubMed  CAS  Google Scholar 

  54. Kurtzke JF. Seizures with promazine, preliminary report. J Nerv Ment Dis 1957; 125: 119–25

    Article  PubMed  CAS  Google Scholar 

  55. Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992; 53: 160–2

    PubMed  CAS  Google Scholar 

  56. Pascual J, Combarros O, Berciano J. Partial status epilepticus following single low dose of chlorimipramine in a patient on MAO-inhibitor treatment. Clin Neuropharmacol 1987; 10: 265–7

    Article  Google Scholar 

  57. Devanand DP, Sackeim HA, Brown RP. Myoclonus during combined tryciclic antidepressant and lithium treatment. J Clin Psychopharm 1988; 8: 446–7

    Article  CAS  Google Scholar 

  58. Avoni P, Riva R, Albani F. Recurrence of absence seizures induced by a low dose of amitriptyline: a case report. Eur J Neurol 1996; 3: 272–4

    Article  PubMed  CAS  Google Scholar 

  59. DeToledo JC, Haddad H, Ramsay RE. Status epilepticus associated with the combination of valproic acid and clomipramine. Ther Drug Monit 1997; 19: 71–3

    Article  PubMed  CAS  Google Scholar 

  60. Miyata H, Kubota F, Shibata N, et al. Non-convulsive status epilepticus induced by antidepressants. Seizure 1997; 6(5): 405–7

    Article  PubMed  CAS  Google Scholar 

  61. Zivin L, Ajmone Marsan C. Incidence and prognostic significance of ‘epileptiform’ activity in the EEG of non-epileptic subjects. Brain 1968; 91: 751–77

    Article  PubMed  CAS  Google Scholar 

  62. Reilly EL, Reed K, Kelley JT. EEG and psychotropic drugs. In: Hughes JR, Wilson WP, editors. EEG and evoked potentials in psychiatry and behavioral neurology. Boston: Butterworths, 1983: 79–99

    Google Scholar 

  63. Sedgwick EM, Edwards JG. Mianserin, maprotiline and the electroencephalogram. Br J Clin Pharmacol 1983; 15: 255–62

    Article  Google Scholar 

  64. Itil TM. Psychotropic drugs and the human EEG. In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography: basic principles, clinical applications and related fields. Baltimore: Urban & Schwarzenberg, 1982: 499–513

    Google Scholar 

  65. Aguglia U, Gambardella A, Le Piane E, et al. Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy. J Neurol 1994; 241: 605–10

    Article  PubMed  CAS  Google Scholar 

  66. Toone BK, Fenton GW. Epileptic seizures induced by psychotropic drugs. Psychol Med 1977; 7: 265–70

    Article  PubMed  CAS  Google Scholar 

  67. Luchins DJ, Oliver AP, Wyatt RJ. Seizures with antidepressants: an in vitro technique to assess relative risk. Epilepsia 1984; 25: 25–32

    Article  PubMed  CAS  Google Scholar 

  68. Oliver AP, Luchins DJ, Wyatt RJ. Neuroleptic-induced seizures: an in vitro technique for assessing relative risk. Arch Gen Psychiatry 1982; 39(2): 206–9

    Article  PubMed  CAS  Google Scholar 

  69. Bauer G. EEG, drug effects, and central nervous system poisoning. In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography: basic principles, clinical applications and related fields. Baltimore: Urban & Schwarzenberg, 1982: 479–89

    Google Scholar 

  70. Fink M. EEG profiles and bioavailability measures of psychoactive drugs. Mod Probl Pharmacopsychiatry 1974; 8: 76–98

    CAS  Google Scholar 

  71. Herrmann WM, Schaerer E. Pharmaco-EEG: computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In: Lopes da Silva FH, Storm van Leeuwen W, Remond A, editors. Handbook of electroencephalography and clinical neurophysiology, revised series. Vol. 2. Amsterdam: Elsevier, 1986: 385–445

    Google Scholar 

  72. Glaze DG. Drug effects. In: Daly DD, Pedley TA, editors. Current practice of clinical electroencephalography. 2nd ed. New York: Raven Press, 1990: 489–512

    Google Scholar 

  73. Helmchen H, Kanowski S. EEG changes under lithium (Li) treatment. Electroencephalogr Clin Neurophysiol 1971; 30: 269

    PubMed  CAS  Google Scholar 

  74. Small JG. EEG and lithium CNS toxicity. Am J EEG Technol 1986; 26: 225–39

    Google Scholar 

  75. Welch J, Manschreck T, Redmond D. Clozapine-induced seizures and EEG changes. J Neuropsychiatry Clin Neurosci 1994; 6: 250–6

    PubMed  CAS  Google Scholar 

  76. Neufeld MY, Rabey JM, Orlov E, et al. Electroencephalographic findings with low-dose clozapine treatment in psychotic parkinsonian patients. Clin Neuropharmacol 1996; 19(1): 81–6

    Article  PubMed  CAS  Google Scholar 

  77. Freudenreich O, Richard D, McEvoy W, et al. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry 1997; 42: 132–7

    Article  PubMed  CAS  Google Scholar 

  78. Schuld A, Kuhn M, Haack M, et al. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 2000; 33: 109–11

    Article  PubMed  CAS  Google Scholar 

  79. Pillmann F, Schlote K, Broich K, et al. Electroencephalogram alterations during treatment with olanzapine. Psychopharmacology 2000; 150: 216–9

    Article  PubMed  CAS  Google Scholar 

  80. Weber JJ. Seizure activity associated with fluoxetine therapy. Clin Pharm 1989; 8: 296–8

    PubMed  CAS  Google Scholar 

  81. Braitberg G, Curry SC. Seizure after isolated fluoxetine overdose. Ann Emerg Med 1995; 26: 234–7

    Article  PubMed  CAS  Google Scholar 

  82. Trabert W, Hohagen F, Winkelmann G, et al. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder. Pharmacopsychiatry 1995; 28: 95–7

    Article  PubMed  CAS  Google Scholar 

  83. Personne M, Sjoberg G, Persson H. Citalopram overdose: review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997; 35: 237–40

    Article  PubMed  CAS  Google Scholar 

  84. Atril PB, Julius DA. Maprotile hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram. J Clin Psychopharmacol 1984; 4: 207–9

    Google Scholar 

  85. Trimble MR. New antidepressant drugs and the seizure threshold. Neuropharmacology 1980; 19: 1227–8

    Article  PubMed  CAS  Google Scholar 

  86. Lefkowitz D, Kilgo G, Lee S. Seizures and trazodone therapy [letter]. Arch Gen Psych 1985; 42: 523

    Article  CAS  Google Scholar 

  87. De Jonghe F, Swinkels JA. The safety of antidepressants. Drugs 1992; 43: 40–7

    Article  PubMed  Google Scholar 

  88. Schindler BA, Ramcandani D. Partial complex status epilepticus in a lithium-toxic patient. Psychosomatics 1993; 4: 521–4

    Article  Google Scholar 

  89. Showron DM, Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy 1992; 12: 18–22

    Google Scholar 

  90. Remick RA, Fine SH. Antipsychotic drugs and seizures. J Clin Psychiatry 1979; 40(2): 78–80

    PubMed  CAS  Google Scholar 

  91. Markowitz JC, Brown RP. Seizures with neuroleptics and antidepressants. Gen Hosp Psychiatry 1987; 9(2): 135–41

    Article  PubMed  CAS  Google Scholar 

  92. Trimble MR. The psychoses of epilepsy and their treatment. Clin Neuropharmacol 1985; 8: 211–20

    Article  PubMed  CAS  Google Scholar 

  93. Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy: a double-blind trial. J Affect Disord 1985; 9: 127–36

    Article  PubMed  CAS  Google Scholar 

  94. Itil TM, Myers JP. Epileptic and anti-epileptic properties of psychotropic drugs. In: Mercier J, editor. Anticonvulsant drugs. International encyclopedia of pharmacology and therapeutics. Vol. 19, No. 2. Oxford: Pergamon, 1973: 599–622

    Google Scholar 

  95. Itil TM. Convulsive and anticonvulsive properties of neuropsychopharmaca. In: Niederland E, editor. Epilepsy: modern problems of pharmacopsychiatry. Vol. 4. New York: Karger, 1970: 270–305

    Google Scholar 

  96. Prien RF, Cole JO. High dose chlorpromazine therapy in chronic schizophrenia. Arch Gen Psychiatry 1968; 18: 482–95

    Article  Google Scholar 

  97. Frommer DA, Kulig KW, Marx GA, et al. Tricyclic antidepressant overdose: a review. JAMA 1987; 257: 521–6

    Article  PubMed  CAS  Google Scholar 

  98. Goel KM, Shanks RM. Amitriptyline and imipramine poisoning in children. BMJ 1974; 1: 261–3

    Article  PubMed  CAS  Google Scholar 

  99. Olson KR, Kearney TE, Dver JE, et al. Seizures associated with poisoning and drug overdose. Am J Emerg Med 1994; 12: 392–5

    Article  PubMed  CAS  Google Scholar 

  100. Preskorn SH, Othmer SC, Lai CW, et al. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations. J Clin Psychopharmacol 1984; 4: 262–4

    Article  PubMed  CAS  Google Scholar 

  101. Boehnert MT, Lovejoy FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313: 474–9

    Article  PubMed  CAS  Google Scholar 

  102. Darby JK, Pasta DJ, Dabiri L, et al. Haloperidol dose and blood level variability: toxicity and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting. J Clin Psychopharmacol 1995; 15(5): 334–40

    Article  PubMed  CAS  Google Scholar 

  103. Richens A, Nawishy S, Trimble MR. Antidepressant drugs, convulsions, and epilepsy. Br J Clin Pharmacol 1983; 15: 295–8

    Article  CAS  Google Scholar 

  104. Perucca E, Manzo L, Crema A. Pharmacokinetic interaction between antiepileptic and psychotropic drugs. In: Trimble MR, editor. The psychopharmacology of epilepsy: Chichester: John Wiley & Sons, 1985: 95–105

    Google Scholar 

  105. Spina E, Perucca E. Newer and older antidepressants: a comparative review of drug interactions. CNS Drugs 1994; 2: 479–87

    Article  Google Scholar 

  106. Monaco F, Cicolin A. Interactions between anticonvulsant and psychoactive drugs. Epilepsia 1999; 40(10 Suppl): 71S–6S

    Article  Google Scholar 

  107. Baldessarini RJ, Teicher MH, Cassidy JW. Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs. J Clin Psychopharmacol 1988; 8: 381–2

    Article  PubMed  CAS  Google Scholar 

  108. Troupin AS, Ojemann LM. Paradoxical intoxication: a complication of anticonvulsant administration. Epilepsia 1975; 16: 753–8

    Article  PubMed  CAS  Google Scholar 

  109. Johnsen SD, Tarby TJ, Sidell AD. Carbamazepine-induced seizures. Ann Neurol 1984; 16: 392–3

    Google Scholar 

  110. Dersun SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet 1993; 342: 442–3

    Article  Google Scholar 

  111. Jalil P. Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports. J Neurol Neurosurg Psychiatry 1992; 55: 412–3

    Article  PubMed  CAS  Google Scholar 

  112. Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy? Epilepsia 1981; 22: 1–10

    Article  PubMed  CAS  Google Scholar 

  113. Fenton GJ. Psychiatric disorders of epilepsy: classification and phenomelogy. In: Reynolds EH, Trimble MR, editors. Epilepsy and psychiatry. Edinburgh: Churchill Livingstone, 1981: 12–26

    Google Scholar 

  114. Perrine K, Congett S. Neurobehavioral problems in epilepsy. Neurol Clin 1994; 12: 129–52

    PubMed  CAS  Google Scholar 

  115. Pauig PM, Deluca MA, Osterheld RG. Thioridazine hydrochloride in the treatment of behavior disorders in epileptics. Am J Psychiatry 1961; 117: 832–3

    PubMed  CAS  Google Scholar 

  116. Ojemann LM, Friel PN, Trejo WJ, et al. Effect of doxepine on seizure frequency in depressed epileptic patients. Neurology 1983; 33: 646–8

    Article  PubMed  CAS  Google Scholar 

  117. Millichap JG. Anticonvulsant drugs. In: Root WS, Hofmann FG, editors. Physiological pharmacology: a comprehensive treatise. New York: Academic Press, 1965: 97–173

    Google Scholar 

  118. Fromm GH, Amores CY, Thies W. Imipramine in epilepsy. Arch Neurol 1972; 27: 198–204

    Article  PubMed  CAS  Google Scholar 

  119. Fromm GH, Rosen JA, Amores CY. A clinical and experimental investigation of the effect of imipramine on epilepsy. Epilepsia 1971; 12: 282–3

    Google Scholar 

  120. Fromm GH, Wessel HB, Glass JD, et al. Imipramine in absence and myoclonic-astatic seizures. Neurology 1978; 28: 953–7

    Article  PubMed  CAS  Google Scholar 

  121. Setiey A, Courjon J. Clomipramine et petit mal. Lyon Med 1978; 239: 751–4

    Google Scholar 

  122. Sakakihara Y, Oka A, Kubota M, et al. Reduction of seizure frequency with clomipramine in patients with complex partial seizures. Brain Dev 1995; 17: 291–3

    Article  PubMed  CAS  Google Scholar 

  123. Favale E, Rubino V, Mainardi P, et al. Anticonvulsant effect of fluoxetine in humans. Neurology 1995; 45: 1926–7

    Article  PubMed  CAS  Google Scholar 

  124. Lange SC, Julien RM, Fowler GW. Biphasic effects of imipramine in experimental models of epilepsy. Epilepsia 1976; 17: 183–96

    Article  PubMed  CAS  Google Scholar 

  125. Vernier VG. The pharmacology of antidepressant agents. Dis Nerv Syst 1961; 22: 7–13

    PubMed  CAS  Google Scholar 

  126. Chen G, Ensor CR, Bohner B. Studies of drug effects on electrically induced extensor seizures and clinical implications. Arch Int Pharmacodyn Ther 1968; 172: 183–218

    PubMed  CAS  Google Scholar 

  127. Stille G, Sayers A. The effect of antidepressant drugs on the convulsive excitability of brain structures. Int J Neuropharmacol 1964; 3: 605–9

    Article  PubMed  CAS  Google Scholar 

  128. Meldrum BS, Anlezark GM, Adam HK, et al. Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon. Psychopharmacology 1982; 76: 212–7

    Article  PubMed  CAS  Google Scholar 

  129. Woods TW, Jobe PC, Laird HE, et al. Anticonvulsant and proconvulsant doses of desipramine in the genetically epilepsyprone rat. Fed Proc 1983; 42: 363

    Google Scholar 

  130. Woods TW, Dailey JW, Reigel CE, et al. Anticonvulsant and proconvulsant effects of doxepin in genetically epilepsy prone rat (GEPR). Fed Proc 1985; 44: 1107

    Google Scholar 

  131. Emori K, Minabe Y, Tanii Y, et al. Effects of chronic treatment with haloperidol and methamphetamine on hippocampal kindled seizures in the cat. Epilepsy Res 1991; 8(3): 213–9

    Article  PubMed  CAS  Google Scholar 

  132. George B, Kulkarni SK. Protective effect of clozapine against pentylenetetrazol convulsions and kindling. Meth Find Exp Clin Pharmacol 1998; 20(5): 395–401

    Article  CAS  Google Scholar 

  133. Koella WP, Glatt A, Klebs K, et al. Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine and amitriptyline. Biol Psychiatry 1979; 14: 485–97

    PubMed  CAS  Google Scholar 

  134. Jobe PC, Woods TW, Dailey JW. Pro-convulsant and anticonvulsant effects of tricyclic antidepressants in genetically epilepsy-prone rats. In: Porter RJ, Mattson J, Richard H, et al., editors. Advances in epileptology: 15th Epilepsy International Symposium. New York: Raven Press, 1984: 187–91

    Google Scholar 

  135. Marescaux C, Hirsch E, Fink S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990; 31: 768–77

    Article  PubMed  CAS  Google Scholar 

  136. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986; 27: 706–10

    Article  PubMed  CAS  Google Scholar 

  137. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487–9

    Article  PubMed  CAS  Google Scholar 

  138. Johnsen SD, Tarby TJ, Sidell AD. Carbamazepine-induced seizures. Ann Neurol 1984; 16: 392–3

    Google Scholar 

  139. Snead OC, Hosey LN. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985; 313: 916–21

    Article  PubMed  Google Scholar 

  140. Callahan DJ, Noetzel MJ. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992; 42: 2198–201

    Article  PubMed  CAS  Google Scholar 

  141. Eeg-Olofsson O, Lindskog U. Acute intoxication with valproate [letter]. Lancet 1982; I: 1306

    Article  Google Scholar 

  142. Koenig SA, Siemes H, Blaker F, et al. Severe hepatotoxicity during valproate therapy: an update and report of eight new cases. Epilepsia 1994; 35: 1005–15

    Article  Google Scholar 

  143. Chadwick DW, Cumming WJK, Livingstone I, et al. Acute intoxication with sodium valproate. Ann Neurol 1979; 6: 552–3

    Article  PubMed  CAS  Google Scholar 

  144. Tassinari CA, Dravet C, Roger J, et al. Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia 1972; 13: 421–35

    Article  PubMed  CAS  Google Scholar 

  145. Prior PF, Maclaine GN, Scott DF, et al. Tonic status epilepticus precipitated by intravenous diazepam in a child with petit mal status. Epilepsia 1972; 13: 467–72

    Article  PubMed  CAS  Google Scholar 

  146. Bittencourt PRM, Richens A. Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome. Epilepsia 1991; 22: 129–34

    Article  Google Scholar 

  147. Di Mario Jr FJ, Calancy RR. Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. Pediatr Neurol 1988; 4: 249–51

    Article  Google Scholar 

  148. Alvarez N, Hartford E, Doubt C. Epileptic seizures induced by clonazepam. Clin Electroencephal 1981; 12: 57–65

    CAS  Google Scholar 

  149. Neufeld MY. Exacerbation of focal seizures due to carbamazepine treatment in an adult patient. Clin Neuropharmacol 1993; 16: 359–61

    Article  PubMed  CAS  Google Scholar 

  150. Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39: 5–17

    Article  PubMed  CAS  Google Scholar 

  151. Trimble MR, Anlezark G, Meldrum BS. Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotonergic mechanisms. Psychopharmacology 1977; 51: 159–64

    Article  PubMed  CAS  Google Scholar 

  152. Altshuler HL, Killam EK, Killam KF. Biogenic amines and the photo-myoclonic syndrome in the baboon, papio papio. J Pharmacol Exp Ther 1976; 196: 156–66

    PubMed  CAS  Google Scholar 

  153. Chadwick D, Jenner P, Reynolds EH. Serotonin metabolism in human epilepsy: the influence of anticonvulsant drugs. Ann Neurol 1977; 1: 218–24

    Article  PubMed  CAS  Google Scholar 

  154. Snead OC. On the sacred disease: the neurochemistry of epilepsy. Int Rev Neurobiol 1983; 24: 93–180

    Article  PubMed  CAS  Google Scholar 

  155. Deahl M, Trimble MR. Serotonin reuptake inhibitors, epilepsy and myoclonus. Br J Psychiatry 1991; 159: 433–5

    Article  PubMed  CAS  Google Scholar 

  156. Wada Y, Nakamura M, Hasegowa H, et al. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus. Neurosci Lett 1992; 141: 21–4

    Article  PubMed  CAS  Google Scholar 

  157. Dailey JW, Reith ME, Steidley KR, et al. Carbamazepine-induced release of serotonin from rat hippocampus in vitro. Epilepsia 1998; 39: 1054–63

    Article  PubMed  CAS  Google Scholar 

  158. Dailey JW, Yan QS, Adams-Curtis LE, et al. Neurochemical correlates of antiepileptic drugs in the genetically epilepsyprone rat (GEPR). Life Sci 1996; 58: 259–66

    Article  PubMed  CAS  Google Scholar 

  159. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995; 34(4): 275–81

    Article  PubMed  CAS  Google Scholar 

  160. Sackeim HA, Decina P, Prohovnik I, et al. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 1983; 18: 1301–10

    PubMed  CAS  Google Scholar 

  161. Post RM, Putnam F, Uhde TW, et al. Electroconvulsive therapy as an anticonvulsant: implications for its mechanism of action in affective illness. In: Malitz S, Sackeim HA, editors. Electroconvulsive therapy: clinical and basic research issues. Ann NY Acad Sci 1986; 462: 376–88

    CAS  Google Scholar 

  162. Coffey CE, Lucke J, Weiner RD, et al. Seizure threshold in electroconvulsive therapy (ECT) II: the anticonvulsant effect of ECT. Biol Psychiatry 1995; 37: 777–88

    Article  PubMed  CAS  Google Scholar 

  163. Harmant J, van Rijckevorsel-Harmant K, DeBarsy T, et al. Fluvoxamine: an antidepressant with low (or no) epileptogenic effect [letter]. Lancet 1990; 336: 386

    Article  PubMed  CAS  Google Scholar 

  164. Reynolds EH. The pharmacological management of epilepsy associated with psychological disorders. Br J Psychiat 1982; 141: 549–57

    Article  CAS  Google Scholar 

  165. Toth P, Frankenburg FR. Clozapine and seizures: a review. Can J Psychiatry 1994; 39(4): 236–8

    PubMed  CAS  Google Scholar 

  166. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapidcycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61(11): 841–50

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors received partial support for 60% of the costs of the article from the University of Messina; no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Neurosciences and of Psychiatric and Anaesthesiological Sciences, First Neurological Clinic, Policiclinico Universitario, The University of Messina, 98125, Contesse Messina, Italy

    Francesco Pisani, Giancarla Oteri, Cinzia Costa, Giorgio Di Raimondo & Raoul Di Perri

Authors
  1. Francesco Pisani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giancarla Oteri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cinzia Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giorgio Di Raimondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raoul Di Perri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Pisani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pisani, F., Oteri, G., Costa, C. et al. Effects of Psychotropic Drugs on Seizure Threshold. Drug-Safety 25, 91–110 (2002). https://doi.org/10.2165/00002018-200225020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200225020-00004

Keywords

Search

Navigation